This inventor holds 1 USPTO granted patent. Top assignee: Zlip Holding Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Fenglan Wu - Innovator in Antigen Binding Units
Introduction
Fenglan Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding units. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Fenglan Wu holds a patent for a CD47 antigen binding unit and its various applications. The patent details antigen binding units that specifically bind to CD47. It also includes polynucleic acids encoding these antigen binding units, vectors comprising the polynucleic acids, and hybridomas and host cells that contain these vectors. Furthermore, the patent outlines methods for inducing phagocytosis of CD47-expressing cells.
Career Highlights
Fenglan Wu is associated with Zlip Holding Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Fenglan Wu collaborates with notable colleagues, including Xu Fang and Jing Li. Their combined expertise enhances the innovative capacity of their projects.
Conclusion
Fenglan Wu is a key figure in the development of antigen binding technologies, with a focus on CD47. His contributions are paving the way for advancements in medical science and therapeutic applications.